Repair & recovery
BPC-157
Written by the Elevate Clinical Team
Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on . Independent clinical review pending.
Also known as Body Protection Compound-157
A synthetic pentadecapeptide sequence studied in preclinical models of tendon, ligament, muscle and gut-lining repair.
What it is
BPC-157 is a 15-amino-acid sequence derived from a protein found in gastric juice. In animal and cell models it has been studied for its effect on angiogenesis — the formation of new blood vessels — and on growth-factor signaling in connective tissue. Almost all of the published work is preclinical; there is very little controlled human data.
What it's studied for
- Tendon and ligament healing in rodent injury models
- Muscle tear and crush-injury recovery in animal studies
- Gastrointestinal lining integrity, including NSAID-related damage
- Angiogenesis and blood-flow signaling around injured tissue
How it's used in practice
- Discussed in research literature in short cycles rather than continuous use
- Frequently paired with TB-500 in published discussions of acute injury
- Often studied alongside loading and rehabilitation protocols, not instead of them
What you should know before asking about it
- Not FDA-approved for any indication and not available from a licensed compounding pharmacy in the United States
- Long-term human safety data does not exist
- Because it influences growth-factor signaling, anyone with an active or prior cancer diagnosis should treat it as contraindicated pending physician review
- Banned by WADA for competitive athletes
Frequently asked questions.
- What is BPC-157?
- BPC-157 is a 15-amino-acid sequence derived from a protein found in gastric juice. In animal and cell models it has been studied for its effect on angiogenesis — the formation of new blood vessels — and on growth-factor signaling in connective tissue. Almost all of the published work is preclinical; there is very little controlled human data.
- What is BPC-157 studied for?
- Published and ongoing research looks at tendon and ligament healing in rodent injury models; muscle tear and crush-injury recovery in animal studies; gastrointestinal lining integrity, including NSAID-related damage; angiogenesis and blood-flow signaling around injured tissue. These are areas of study, not promised outcomes.
- Is BPC-157 FDA-approved?
- BPC-157 has not been evaluated by the FDA. Elevate Chicago lists it for education and research reference only — it is not prescribed as medical care and is not intended for human consumption.
- How is BPC-157 typically used?
- Discussed in research literature in short cycles rather than continuous use Frequently paired with TB-500 in published discussions of acute injury Often studied alongside loading and rehabilitation protocols, not instead of them Any specific dose, frequency or duration comes from a prescription written for you after labs — never from this page.
- What are the risks and unknowns with BPC-157?
- Not FDA-approved for any indication and not available from a licensed compounding pharmacy in the United States Long-term human safety data does not exist Because it influences growth-factor signaling, anyone with an active or prior cancer diagnosis should treat it as contraindicated pending physician review Banned by WADA for competitive athletes
Sources
- 1.Published literature on BPC-157 Body Protection Compound-157— PubMed, U.S. National Library of Medicine
- 2.Compounding and the FDA: questions and answers— U.S. Food & Drug Administration
- 3.Bulk drug substances nominated for use in compounding under section 503A— U.S. Food & Drug Administration
- 4.Test directory and patient service center locator— Quest Diagnostics
About this page
Written by the Elevate Clinical Team
Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on . Independent clinical review pending. Educational content only — not medical advice, not a diagnosis, and not an offer to sell any prescription product.
This page is educational reference material. It is not medical advice, not a diagnosis, and not an offer to sell any product. Prescription therapies are dispensed only through licensed, FDA-registered compounding pharmacies after a physician evaluation. Compounds identified as research use only are not FDA-approved, are not prescribed as medical care, and are not intended for human or animal consumption. Availability, formulations and regulatory status change over time.
More in Repair & recovery
TB-500
A fragment of thymosin beta-4 studied for cell migration, flexibility and scar remodeling in preclinical injury models.
GHK-Cu
A naturally occurring copper-binding tripeptide studied for collagen synthesis, skin quality and gene-expression effects.
KPV
A short alpha-MSH fragment studied for anti-inflammatory signaling in gut and skin models.